Influence of mammographic screening on breast cancer incidence trends in South Australia

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 7, 2014, Pages 3105-3112

  Beckmann, Kerri Rose ^a   Roder, David Murray ^c   Hiller, Janet Esther ^b   Farshid, Gelareh ^a   Lynch, John William ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Ambulance Service of NSW   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Breast cancer; Incidence trends; Mammographic screening

Indexed keywords

ADULT; AGED; AUSTRALIA; BREAST NEOPLASMS; DRINKING BEHAVIOR; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAMMOGRAPHY; MIDDLE AGED; OBESITY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; AUSTRALIA; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; OBESITY; RISK FACTORS;

EID: 84900848469     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.7.3105     Document Type: Article

References (36)

1. Australian Bureau of Statistics (2008). 3105.0.65.001-Australian Historical Population Statistics, 2008 Canberra, ABS.
2. Australian Bureau of Statistics (2009). Smoking, risky drinking and obesity 4102.0-Australain Social Trends, Dec 2009. Canberra, ABS.
3. Australian Bureau of Statistics (2012). 3101.0-Australian Demographic Statisitics, June 2012. Canberra, ABS.
4. Australian Institute of Health and Welfare: Dixon T, Walters A (2003). A growing problem: trends and patterns in overweight and obesity among adult Australians, 1980 to 2001 Canberra, AIHW.
5. Bray F, McCarron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39.
6. BreastScreen SA (2010). The impact of BreastScreen SA, 20 year report 1989-2008: with trend data for 1989-2004. S. H. Central Northern adelaide health service. Adelaide government of South Australia
7. Brooks PJ, Zakhari S (2013). Moderate alcohol consumption and breast cancer in women: from epidemiology to mechanisms and interventions. Alcohol Clin Exp Res, 37, 23-30.
8. Canfell K, Banks E, Moa AM, Beral V (2008). Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Aust, 188, 641-4.
9. Chlebowski RT, Hendrix SL, Langer RD, et al (2003). Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA, 289, 3243-53.
10. Chlebowski RT, Kuller LH, Prentice RL, et al (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med, 360, 573-87.
11. Cleary MP, Grossmann ME (2009). Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology, 150, 2537-42.
12. Collaborative Group on Hormonal Factors in Breast Cancer (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer Collaborative group on hormonal factors in breast cancer. Lancet, 350, 1047-59.
13. Daubisse-Marliac L, Delafosse P, Boitard JB, et al (2011). Breastcancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol, 22, 329-34.
14. de Gelder R (2011). Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev, 33.
15. De Prithwish C, Neutel CI, Olivotto I, Morrison H (2010). Breast cancer incidence and hormone replacement therapy in Canada. J Natl Cancer Inst, 102, 1489-95.
16. Dietel M (2010). Hormone replacement therapy (HRT), breast cancer and tumor pathology. Maturitas, 65, 183-9.
17. Duffy SW, Parmar D (2013). Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res, 15, 41.
18. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE (2006). Adult weight change and risk of postmenopausal breast cancer. JAMA, 296, 193-201.
19. Ewertz M, Duffy SW, Adami HO, et al (1990). Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer, 46, 597-603.
20. Glass AG, Lacey JV, Jr., Carreon JD, Hoover RN (2007). Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst, 99, 1152-61.
21. Gompel A, Plu-Bureau G (2010). Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy. Ann N YAcad Sci, 1205, 268-76.
22. Hofvind S, Sakshaug S, Ursin G, Graff-Iversen S (2012). Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening. Int J Cancer, 130, 2930-8.
23. Holford TR, Cronin KA, Mariotto AB, Feuer EJ (2006). Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr, 36, 19-25.
24. International Agency for Research on Cancer (2008). World cancer report 2008. P. Boyle and L. B. Lyon IARC Press
25. Jemal A, Ward E, Thun MJ (2007). Recent trends in breast cancer incidence rates by age and tumor characteristics among US women. Breast Cancer Res, 9, 28.
26. Kelsey JL, Gammon MD, John EM (1993). Reproductive factors and breast cancer. Epidemiol Rev, 15, 36-47.
27. Krieger N, Chen JT, Waterman PD (2010). Decline in US breast cancer rates after the women's health initiative: socioeconomic and racial/ethnic differentials. Am J Public Health, 100, 132-9.
28. Luke C, Priest K, Roder D (2006). Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening. Asian Pac J Cancer Prev, 7, 69-74.
29. Nassar A (2011). Core needle biopsy versus fine needle aspiration biopsy in breast-- a historical perspective and opportunities in the modern era. Diagn Cytopathol, 39, 380-8.
30. National Cancer Insitute (2012). Joinpoint Regression Program, Version 3.5.4-Aug 2012. Statisitical Methodology and Applications Branch. Bethesda, MD., NCI.
31. Paci E, Duffy S (2005). Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res, 7, 266-70.
32. Puliti D, Duffy SW, Miccinesi G, et al (2012). Overdiagnosis in mammography screening for breast cancer in Europe: a literature review. J Med Screen, 19, 42-56.
33. Roder D, de Silva P, Zorbas H, et al (2012). Survival from synchronous bilateral breast cancer: the experience of surgeons participating in the breast audit of the society of Breast Surgeons of Australia and New Zealand. Asian Pac J Cancer Prev, 13, 1413-8.
34. Roder D, Zorbas H, Kollias J, et al (2013). Factors predictive of Kerri Rose Beckmann et al treatment by Australian breast surgeons of invasive female breast cancer by mastectomy rather than breast conserving surgery. Asian Pac J Cancer Prev, 14, 539-45.
35. Wilson DH, Wakefield M, Taylor AW (1992). The south australian health omibus survey. Health Promotion J Aust, 2, 47-9.
36. Zbuk K, Anand SS (2012). Declining incidence of breast cancer after decreased use of hormone-replacement therapy: magnitude and time lags in different countries. J Epidemiol Community Health, 66, 1-7.